Patents by Inventor Stephen Moss

Stephen Moss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR MAKING AN ARTICLE OF MANUFACTURE ON A SINGLE, CONTINUOUS MANUFACTURING LINE
    Publication number: 20240167197
    Abstract: A process, for example a continuous process, for making an article of manufacture containing a fibrous structure, for example a composite structure, and more particularly to a process for making an article of manufacture containing a fibrous structure, such as a soluble fibrous structure, containing soluble filaments is provided.
    Type: Application
    Filed: February 2, 2024
    Publication date: May 23, 2024
    Inventors: Anthony Edward REED, Michael Sean PRATT, Paul R. MORT, III, Stephen Robert GLASSMEYER, Dinah Achola NYANGIRO, Mark William HAMERSKY, Richard Allen DIEMAR, Jeffrey Moss VAUGHN, Gavin John BROAD, Gregory Charles GORDON, Frank William DENOME, Mark Robert SIVIK, Andreas Josef DREHER
  • URIDINE DIPHOSPHATE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20210347807
    Abstract: This disclosure relates to uridine diphosphate (UDP) derivatives, compositions comprising therapeutically effective amounts of those UDP derivatives and methods of using those derivatives or compositions in treating disorders that are responsive to ligands, such as agonists, of P2Y6 receptor, e.g., neuronal disorders, including neurodegenerative disorders (e.g., Alzheimer's disease) and traumatic CNS injury, as well as pain.
    Type: Application
    Filed: July 26, 2021
    Publication date: November 11, 2021
    Inventors: Philip G. Haydon, Jinbo Lee, Jinghui Dong, Stephen Moss, Raquel Revilla-Sanchez
  • Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders
    Patent number: 11072627
    Abstract: This disclosure relates to uridine diphosphate (UDP) derivatives, compositions comprising therapeutically effective amounts of those UDP derivatives and methods of using those derivatives or compositions in treating disorders that are responsive to ligands, such as agonists, of P2Y6 receptor, e.g., neuronal disorders, including neurodegenerative disorders (e.g., Alzheimer's disease) and traumatic CNS injury, as well as pain.
    Type: Grant
    Filed: December 3, 2018
    Date of Patent: July 27, 2021
    Assignee: Tufts University
    Inventors: Philip G. Haydon, Jinbo Lee, Jinghui Dong, Stephen Moss, Raquel Revilla-Sanchez
  • TREATMENT
    Publication number: 20200330591
    Abstract: The invention provides an antibody or fragment thereof that specifically binds to human Lrg1.
    Type: Application
    Filed: December 27, 2019
    Publication date: October 22, 2020
    Applicant: UCL Business Ltd
    Inventors: Vineeta TRIPATHI, Rose SHERIDAN, John GREENWOOD, Stephen MOSS
  • Antibody which binds Lrg1 and methods of use
    Patent number: 10556007
    Abstract: The invention provides an antibody or fragment thereof that specifically binds to human Lrg1.
    Type: Grant
    Filed: February 22, 2016
    Date of Patent: February 11, 2020
    Assignee: UCL Business LTD
    Inventors: Vineeta Tripathi, Rose Sheridan, John Greenwood, Stephen Moss
  • URIDINE DIPHOSPHATE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20190309009
    Abstract: This disclosure relates to uridine di phosphate (UDP) derivatives, compositions comprising therapeutically effective amounts of those UDP derivatives and methods of using those derivatives or compositions in treating disorders that are responsive to ligands, such as agonists, of P2Y6 receptor, e.g., neuronal disorders, including neurodegenerative disorders (e.g., Alzheimer's disease) and traumatic CNS injury, as well as pain.
    Type: Application
    Filed: December 3, 2018
    Publication date: October 10, 2019
    Inventors: Philip G. Haydon, Jinbo Lee, Jinghui Dong, Stephen Moss, Raquel Revilla-Sanchez
  • Cleansing compositions and methods of use thereof
    Patent number: 9949910
    Abstract: A method of improving the rinsability of a cleansing composition comprising an isethionate ester surfactant of formula R6COOCH2CH2SO3?M+ the method comprising incorporating into the composition one or more compounds of formula (I) wherein R1 and R6 each independently represents a C4-36 substituted or unsubstituted hydrocarbyl group; each of R2, R3, R4 and R5 independently represents a hydrogen atom or a C1-4 alkyl group and wherein at least one of R2, R3, R4 and R5 is not hydrogen and M+ represents a cation.
    Type: Grant
    Filed: December 20, 2012
    Date of Patent: April 24, 2018
    Assignee: INNOSPEC LIMITED
    Inventors: John Nucci, Stephen Moss O'Connor
  • TREATMENT
    Publication number: 20180028609
    Abstract: The invention provides an antibody or fragment thereof that specifically binds to human Lrg1.
    Type: Application
    Filed: February 22, 2016
    Publication date: February 1, 2018
    Applicant: UCL Business PLC
    Inventors: Vineeta TRIPATHI, Rose SHERIDAN, John GREENWOOD, Stephen MOSS
  • Treatment of vasculoproliferative conditions with Lrg1 antagonists
    Patent number: 9708397
    Abstract: This invention relates to the field of molecular physiology. Specifically, this invention relates to the treatment of vasculoproliferative conditions, especially those of the eye and in the treatment of tumours that exhibit vascular proliferation. Levels of leucine-rich alpha-2-glycoprotein (Lrg1) have been demonstrated to be increased in patients suffering from such conditions and animal models of such conditions. Antagonists of Lrg1 can be used to treat vasculoproliferative conditions.
    Type: Grant
    Filed: June 23, 2014
    Date of Patent: July 18, 2017
    Inventors: John Greenwood, Stephen Moss, Xiaomeng Wang
  • High power radio frequency (RF) in-line wafer testing
    Patent number: 9599657
    Abstract: Approaches for performing in line wafer testing are provided. An approach includes a method that includes generating a radio frequency (RF) test signal, and applying the RF test signal to a device under test (DUT) in a wafer using a buckling beam probe set with a predefined pitch. The method also includes detecting an output RF signal from the DUT in response to the applying the RF test signal to the DUT, and sensing at least one frequency component of the detected output RF signal.
    Type: Grant
    Filed: January 3, 2013
    Date of Patent: March 21, 2017
    Assignee: GLOBALFOUNDRIES INC.
    Inventors: Hanyi Ding, John Ferrario, Barton E. Green, Stephen Moss, Mustapha Slamani
  • Composition comprising fatty acyl isethionate and synthetic wax and method producing the same
    Patent number: 9593298
    Abstract: A method of preparing a component of a personal care bar, the method comprising: (a) providing a composition comprising an isethionate surfactant at a temperature of at least 20° C.; (b) combining the composition comprising the isethionate surfactant with a synthetic 5 wax and optional further components at a temperature of at least 120° C.; and (c) cooling the mixture obtained in step (b).
    Type: Grant
    Filed: June 14, 2012
    Date of Patent: March 14, 2017
    Assignee: Innospec Limited
    Inventors: Phillip Loraine Cotrell, Philip Arie Matena, Stephen Moss O'Connor
  • Carrier comprising a vitamin E derivative
    Patent number: 9545392
    Abstract: A pharmaceutical composition is provided comprising a vitamin E derivative, an anionic phopholipid-binding protein, an anionic phospholipid and a sterol. Also provided is a method for preparing a composition for delivering a cargo to a subject comprising a) forming liposomes from a vitamin E derivative, an anionic phospholipid-binding protein such as annexin, an anionic phospholipid such as phosphatidylserine and a sterol; and b) encapsulating the cargo in the liposomal composition.
    Type: Grant
    Filed: March 29, 2010
    Date of Patent: January 17, 2017
    Assignee: UCL BUSINESS PLC
    Inventors: Francesca Cordeiro, Stephen Moss, Katy Coxon, James Duggan
  • Pharmaceutical composition comprising a Vitamin E derivative and a cell death marker
    Patent number: 9539203
    Abstract: The invention relates to a carrier for delivering agents to the posterior region of the eye, the carrier comprising a Vitamin E derivative, especially tocopherol. The carrier may also comprise a cell death marker, such as an annexin.
    Type: Grant
    Filed: December 19, 2008
    Date of Patent: January 10, 2017
    Assignee: UCL BUSINESS PLC
    Inventors: Francesca Cordeiro, Stephen Moss
  • URIDINE DIPHOSPHATE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20160318968
    Abstract: This disclosure relates to uridine di phosphate (UDP) derivatives, compositions comprising therapeutically effective amounts of those UDP derivatives and methods of using those derivatives or compositions in treating disorders that are responsive to ligands, such as agonists, of P2Y6 receptor, e.g., neuronal disorders, including neurodegenerative disorders (e.g., Alzheimer's disease) and traumatic CNS injury, as well as pain.
    Type: Application
    Filed: January 4, 2016
    Publication date: November 3, 2016
    Inventors: Philip G. Haydon, Jinbo Lee, Jinghui Dong, Stephen Moss, Raquel Revilla-Sanchez
  • Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders
    Patent number: 9227993
    Abstract: This disclosure relates to uridine diphosphate (UDP) derivatives, compositions comprising therapeutically effective amounts of those UDP derivatives and methods of using those derivatives or compositions in treating disorders that are responsive to ligands, such as agonists, of P2Y6 receptor, e.g., neuronal disorders, including neurodegenerative disorders (e.g., Alzheimer's disease) and traumatic CNS injury, as well as pain.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: January 5, 2016
    Assignee: TUFTS UNIVERSITY
    Inventors: Philip G. Haydon, Jinbo Lee, Jinghui Dong, Stephen Moss, Raquel Revilla-Sanchez
  • TREATMENT OF CANCER
    Publication number: 20150132226
    Abstract: This invention relates to the field of molecular physiology. Specifically, this invention relates to the prevention and/or treatment of cancer. Leucine-rich alpha-2-glycoprotein (Lrg1) has been demonstrated to be expressed in a range of cancer cells. Antagonists of Lrg1 can be used to prevent and/or treat cancer by an effect on neoplastic cells.
    Type: Application
    Filed: March 8, 2013
    Publication date: May 14, 2015
    Inventors: John Greenwood, Stephen Moss, Xiaomeng Wang
  • Quantifying cell death
    Patent number: 9014457
    Abstract: The invention relates to methods of diagnosis, particularly methods of staging and diagnosing neurodegenerative diseases using images of cell death in the eye.
    Type: Grant
    Filed: November 5, 2010
    Date of Patent: April 21, 2015
    Assignee: UCL Business PLC
    Inventors: Stephen Moss, Maria Francesca Cordeiro, Steven Dakin
  • URIDINE DIPHOSPHATE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20150045319
    Abstract: This disclosure relates to uridine diphosphate (UDP) derivatives, compositions comprising therapeutically effective amounts of those UDP derivatives and methods of using those derivatives or compositions in treating disorders that are responsive to ligands, such as agonists, of P2Y6 receptor, e.g., neuronal disorders, including neurodegenerative disorders (e.g., Alzheimer's disease) and traumatic CNS injury, as well as pain.
    Type: Application
    Filed: July 3, 2014
    Publication date: February 12, 2015
    Inventors: Philip G. Haydon, Jinbo Lee, Jinghui Dong, Stephen Moss, Raquel Revilla-Sanchez
  • Cosmetics bottle
    Patent number: D929869
    Type: Grant
    Filed: September 9, 2019
    Date of Patent: September 7, 2021
    Assignee: Victoria's Secret Stores Brand Management, LLC
    Inventors: Stephen Moss, Alyson Aversa, Karin Kleen, Sandra Monteparo
  • Cosmetics bottle
    Patent number: D974918
    Type: Grant
    Filed: February 16, 2021
    Date of Patent: January 10, 2023
    Assignee: Victoria's Secret Stores Brand Management, LLC
    Inventors: Jessica Libby, Stephen Moss, Sandra Monteparo, Jeffrey Uhl